News & Events
News, industry insights and noteworthy events.
At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.
For media or press inquiries, please email us.
Contact UsAll Articles
-
Proveca and Tanner Pharma initiate global Managed Access Program for Sialanar®
For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. Sialanar is for the treatment of sialorrhea, or chronic drooling, in…
Read More -
Tanner Pharma Group Signs Exclusive Distribution Agreement with Merz North America for Named Patient Sales of Cuvposa® (glycopyrrolate) oral solution into Emerging Markets
New access for children in Latin American markets with neurologic conditions that cause chronic severe drooling Tanner Pharma Group, a global provider of integrated specialty access solutions, announces the signing of an exclusive distribution agreement with Merz North America, a specialty healthcare company with a strong commitment to the U.S. neurosciences space. The agreement names…
Read More